Camanio Care clarifies liquidity position and establish timeline for rights issue
Camanio Care has earlier communicated the intent to do a new rights issue of shares during the spring. Now the timeline has been finalized and the ambition is that the new issue will be done at the latest during April. More details for the new issue have not yet been decided but will be communicated promptly when details are available. The company today has enough cash to finance the operations of the company until the end of April.
In connection to the issue made by Camanio during the fall of 2018, it was communicated that liquidity allowed for the cash flow to be handled until the end of February. Thanks to a strong growth during the fourth quarter, the cash is now considered enough to last until the end of April.
Camanio Care still retains the option for further financing by issuing new convertible debt instruments to the European Select Growth Opportunities Fund, in accordance with a previously entered agreement.
The company has previously communicated the intention to change listing to First North. The board of directors has been strengthened as part of the work to evaluate this, but no formal application has yet been submitted.
For more information, please contact:
Catharina Borgenstierna, CEO
Telephone: +46 733-93 00 07
About Camanio Care
Camanio Care is a care technology company developing smart solutions for digital home care with the individual in focus. The company offers digital service platforms, products and services, such as Vital Smart Care, ICE, BikeAround, Bestic and Giraff. Through optimizing the mix of physical and digital care, Camanio Care works to support the basic needs of individuals and increasing the freedom, efficiency and quality of care. Camanio Care has its headquarters in Stockholm, the subsidiary Camanio Care Inc. in the U.S., and distributors in Asia, Middle East, Hongkong, Australia and tens of European countries.
Visit our website and subscribe to our newsletter, www.camanio.com.
This information is information that Camanio Care is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, on 26 February, 2019..